Bandingkan Harga & Kinerja Intra Golflink Resorts Tbk. (GOLF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Intra Golflink Resorts Tbk. dan Organon Pharma Indonesia Tbk.: Intra Golflink Resorts Tbk. diperdagangkan di Rp180 (kapitalisasi pasar 3,43 T, volume 24 jam 37,54 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Intra Golflink Resorts Tbk. jauh lebih besar — sekitar 32,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GOLF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,43 T | 104,4 M |
Volume | 37,54 jt | — |
Lot | 375,36 rb | — |
Perputaran | 6,84 M | — |
Harga Rata-rata | 182,24 | — |
Nilai Transaksi | 6,84 M | — |
Harga Ekuilibrium Indikatif | 180 | — |
Volume Ekuilibrium Indikatif | 3,11 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Intra Golflink Resorts Tbk.
PT Intra Golflink Resorts Tbk (the Company) was established under the name of PT Dreamland Pecatu Golf based on Notarial Deed No. 32 dated February 22, 2005 of Robert Purba, S.H., notary in Jakarta. The Company started its commercial operations in June 2006. The Company immediate and ultimate parent entity is PT Bali Pecatu Graha, domiciled in Bali. H. Hutomo Mandala Putra, S.H., is the ultimate beneficial owner and controlling party of the Company.
Selengkapnya di halaman GOLF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
